Experimental drug aims to shield celiac patients from Gluten's harm

NCT ID NCT06001177

Completed Disease control Sponsor: Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA Source: ClinicalTrials.gov ↗

Summary

This study tested whether an investigational drug called KAN-101 could protect the intestines of people with celiac disease from damage caused by accidentally eating gluten. Fifty-five adults who follow a strict gluten-free diet were given either KAN-101 or a placebo and then underwent a controlled gluten challenge. The main goal was to see if the drug could lessen the gut damage typically caused by gluten exposure.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Albert Schweitzer Ziekenhuis, locatie Dordwijk

Dordrecht, South Holland, 3318AT, Netherlands
Alliance for Multispecialty Research, LLC

Wichita, Kansas, 67207, United States
Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
CRST Helsinki Oy

Helsinki, Uusimaa, 00180, Finland
Centre Intégré de Santé et de Services Sociaux-Chaudière Appalaches - Hôtel-Dieu de Lévis

Lévis, Quebec, G6V 3Z1, Canada
Centrum Medyczne Med-Gastr Sp. z o.o.

Lodz, Łódź Voivodeship, 91-034, Poland
Clinical Research Services Turku

Turku, Southwest Finland, 20520, Finland
Connolly Hospital

Dublin, Dublin, D15X40D, Ireland
Diex Recherche Quebec Inc.

Québec, Quebec, G1V 4T3, Canada
Gastromed Sp. z o. o.

Torun, Kuyavian-Pomeranian Voivodeship, 87-100, Poland
Homestead Associates in Research Inc.

Miami, Florida, 33032, United States
Hopital Du Sacre-Coeur De Montreal

Montreal, Quebec, H4J 1C5, Canada
LHSC

London, Ontario, N6A 5W9, Canada
MZ Badania Slowik Zymla Spolka Jawna

Knurów, Silesian Voivodeship, 44-190, Poland
McMaster University

Hamilton, Ontario, L8S 4L8, Canada
Melita Medical

Wroclaw, Lower Silesian Voivodeship, 50-449, Poland
Midland Regional Hospital Mullingar

Mullingar, Westmeath, N91Na43, Ireland
Ochsner Clinic Foundation

New Orleans, Louisiana, 70121, United States
Our Lady of Lourdes Hospital

Drogheda, Louth, A92VW28, Ireland
Peak Gastroenterology Associates

Colorado Springs, Colorado, 80907, United States
Rabin Medical Center

Petah Tikva, Central District, 4941492, Israel
Shaare Zedek Medical Center

Jerusalem, Jerusalem, 9103102, Israel
Sheba Medical Center

Ramat Gan, Central District, 5265601, Israel
Soroka Medical Center

Beersheba, Southern District, 8410101, Israel
Studiengesellschaft BSF Unternehmergesellschaft

Halle, Saxony-Anhalt, 6108, Germany
Tays Research Services

Tampere, Pirkanmaa, 33520, Finland
Unlimited Medical Research Group

Hialeah Gardens, Florida, 33018, United States
WIP Warsaw IBD Point Profesor Kierkuś

Warsaw, Masovian Voivodeship, 00-728, Poland

Conditions

Explore the condition pages connected to this study.

CELIAC DISEASE COELIAC DISEASE